UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

Seminars in immunology, 2018-10, Vol.39, p.14-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

Expert review of vaccines, 2017-01, Vol.16 (1), p.55-63

2017

Link zum Volltext

Verfügbarkeit prüfen

The how's and what's of vaccine reactogenicity

npj vaccines, 2019-09, Vol.4 (1), p.39-39, Article 39

2019

Link zum Volltext

Verfügbarkeit prüfen

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Nature communications, 2022-07, Vol.13 (1), p.3840-3840, Article 3840

2022

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1920-1930

2014

Link zum Volltext

Verfügbarkeit prüfen

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

Expert review of vaccines, 2012-03, Vol.11 (3), p.349-366

2012

Link zum Volltext

Verfügbarkeit prüfen

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

Frontiers in immunology, 2017-08, Vol.8, p.943-943

2017

Link zum Volltext

Verfügbarkeit prüfen

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e1037-e1045

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine, 2021-05, Vol.39 (22), p.3053-3066

2021

Link zum Volltext

Verfügbarkeit prüfen

Co-administration of COVID-19 and influenza vaccines

Clinical microbiology and infection, 2023-05, Vol.29 (5), p.558-559

2023

Link zum Volltext

Verfügbarkeit prüfen

Towards an evidence based approach for the development of adjuvanted vaccines

Current opinion in immunology, 2017-08, Vol.47, p.93-102

2017

Link zum Volltext

Verfügbarkeit prüfen

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

The Journal of immunology (1950), 2009-11, Vol.183 (10), p.6186-6197

2009

Link zum Volltext

Verfügbarkeit prüfen

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

Cell reports (Cambridge), 2021-10, Vol.37 (1), p.109773-109773, Article 109773

2021

Link zum Volltext

Verfügbarkeit prüfen

One-year Longitudinal Study of Antibody Profiles in Children: MIS-C Versus Children With Uncomplicated COVID-19

The Pediatric infectious disease journal, 2024-05, Vol.43 (5), p.e189

2024

Link zum Volltext

Verfügbarkeit prüfen

Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

Clinical microbiology and infection, 2021-05, Vol.27 (5), p.784.e1-784.e8

2021

Link zum Volltext

Verfügbarkeit prüfen

Commentary on “Common Vaccines and the Risk of Dementia: A Population-Based Cohort Study”: Science Can be Messy but Eventually Leads to Truths

The Journal of infectious diseases, 2023-05, Vol.227 (11), p.1224-1226

2023

Link zum Volltext

Verfügbarkeit prüfen

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

JAMA neurology, 2022-04, Vol.79 (4), p.399

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Vaccine, 2019-03, Vol.37 (14), p.2004-2015

2019

Link zum Volltext

Verfügbarkeit prüfen

Central Role of CD169 + Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01

Scientific reports, 2016-12, Vol.6 (1), p.39475-39475, Article 39475

2016

Link zum Volltext

Verfügbarkeit prüfen

A critical function for CD200 in lung immune homeostasis and the severity of influenza infection

Nature immunology, 2008-09, Vol.9 (9), p.1074-1083

2008

Link zum Volltext

Verfügbarkeit prüfen

Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults

Vaccine, 2022-04, Vol.40 (19), p.2714-2722

2022

Link zum Volltext

Verfügbarkeit prüfen

Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

Vaccine, 2020-06, Vol.38 (31), p.4783-4791

2020

Link zum Volltext

Verfügbarkeit prüfen

Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01

European journal of immunology, 2019-12, Vol.49 (12), p.2134-2145

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Expert review of vaccines, 2018-07, Vol.17 (7), p.619-634

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(78)

Publikationsform

Artikel
(87)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

The how's and what's of vaccine reactogenicity

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Co-administration of COVID-19 and influenza vaccines

Towards an evidence based approach for the development of adjuvanted vaccines

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

One-year Longitudinal Study of Antibody Profiles in Children: MIS-C Versus Children With Uncomplicated COVID-19

Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

Commentary on “Common Vaccines and the Risk of Dementia: A Population-Based Cohort Study”: Science Can be Messy but Eventually Leads to Truths

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Central Role of CD169 + Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01

A critical function for CD200 in lung immune homeostasis and the severity of influenza infection

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response

Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults

Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Aktive Filter

Suchergebnisse filtern